What is Netmeds?
Netmeds operates as a fully licensed e-pharma portal, bridging the gap between traditional pharmacy services and digital convenience. The platform provides a comprehensive suite of services, including the authenticated delivery of prescription medications and a wide array of Over-the-Counter (OTC) health and personal care products. Central to its value proposition is a rigorous verification process, where qualified pharmacists review prescriptions for validity and dosage, ensuring patient safety and regulatory compliance. By digitizing the pharmacy experience, Netmeds addresses the needs of patients managing chronic conditions as well as those seeking lifestyle and wellness goods, effectively positioning itself as a critical node in the digital health ecosystem.
How much funding has Netmeds raised?
Netmeds has raised a total of $64M across 2 funding rounds:
Unspecified
$50M
Private Equity
$14M
Unspecified (2015): $50M with participation from MAPE Advisory Group and OrbiMed
Private Equity (2017): $14M led by Sistema Asia Fund
Key Investors in Netmeds
MAPE Advisory Group
A prominent Indian investment bank specializing in M&A and Private Equity advisory services, known for navigating complex financial transactions.
OrbiMed
A specialized investment firm focused exclusively on the healthcare sector, managing capital across biopharmaceuticals, medical devices, and digital health platforms.
Sistema Asia Fund
A large private investor and holding company with a diverse portfolio spanning telecommunications, high technology, and healthcare sectors.
What's next for Netmeds?
With the support of its recent strategic investment, Netmeds is well-positioned to accelerate its market penetration and enhance its technological infrastructure. The company is expected to focus on optimizing its supply chain logistics and expanding its reach to underserved regions, thereby increasing the accessibility of essential medicines. Furthermore, the integration of advanced data analytics and potential service diversification could allow Netmeds to deepen its engagement with its user base, moving beyond simple transaction-based interactions toward a more holistic health management platform. As the e-pharma sector continues to evolve, the firm's ability to maintain its regulatory standards while scaling operations will be the primary determinant of its long-term market leadership.
See full Netmeds company page
